Robert S. Witte
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 3
- Colorectal Cancer Treatments and Studies 2
-
- Renal cell carcinoma treatment 5
- Co-authors
- Paul Elson (6 shared papers)Donald L. Trump (7 shared papers)Patrick J. Loehrer (3 shared papers)Robert Dreicer (1 shared paper)Richard H. Knop (1 shared paper)Bartholomew R. Bono (1 shared paper)D L Trump (2 shared papers)J. Thomas Rosenthal (1 shared paper)
- Journals
- Investigational New Drugs (8 papers)Cancer (3 papers)Journal of Clinical Oncology (2 papers)Journal of Applied Physics (2 papers)The Journal of Chemical Physics (2 papers)
- Partner nations
- United StatesSouth AfricaPhilippines
In The Last Decade
Robert S. Witte
30 papers receiving 905 citations
Peers
Comparison fields: 5 of 105
- Oncology 378
- Pulmonary and Respiratory Medicine 402
- Cancer Research 127
- Surgery 326
- Molecular Biology 262
Countries citing papers authored by Robert S. Witte
This map shows the geographic impact of Robert S. Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Witte more than expected).
Fields of papers citing papers by Robert S. Witte
This network shows the impact of papers produced by Robert S. Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Witte. The network helps show where Robert S. Witte may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert S. Witte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. | 1988 | 262 |
| 2 | 1997 | 155 | |
| 3 | 1996 | 104 | |
| 4 | Phase I study of vinblastine and verapamil given by concurrent iv infusion. | 1985 | 67 |
| 5 | 2003 | 54 | |
| 6 | 1994 | 41 | |
| 7 | 1998 | 38 | |
| 8 | 1991 | 31 | |
| 9 | 1987 | 31 | |
| 10 | 1986 | 19 | |
| 11 | 1962 | 18 | |
| 12 | 1996 | 17 | |
| 13 | 1999 | 16 | |
| 14 | 1951 | 16 | |
| 15 | 1963 | 13 | |
| 16 | 1964 | 12 | |
| 17 | 1992 | 11 | |
| 18 | 1962 | 10 | |
| 19 | 1959 | 9 | |
| 20 | 2001 | 7 |
About Robert S. Witte
Robert S. Witte is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Surgery, having authored 30 papers that have together received 964 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Lung Cancer Research Studies (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (378 citations), Pulmonary and Respiratory Medicine (402 citations), Cancer Research (127 citations), Surgery (326 citations) and Molecular Biology (262 citations). Robert S. Witte has collaborated with scholars based in United States, South Africa and Philippines. Frequent co-authors include Paul Elson, Donald L. Trump, Patrick J. Loehrer, Robert Dreicer, Richard H. Knop, Bartholomew R. Bono, D L Trump, J. Thomas Rosenthal, Thomas P. Davis and Harry Fisher. Their work appears in journals such as Investigational New Drugs, Cancer, Journal of Clinical Oncology, Journal of Applied Physics and The Journal of Chemical Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.